Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis

Journal of the Neurological Sciences

Volumn 218, Issue 1-2, 2004, Pages 29-37

  Verkkoniemi, Auli ^a,b   Ylikoski, Raija ^a   Rinne, Juha O ^c   Somer, Mirja ^d   Hietaharju, Aki ^e   Erkinjuntti, Timo ^a   Viitanen, Matti ^f,g   Kalimo, Hannu ^c,h   Haltia, Matti ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d Vaestoliitto   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF TURKU   (Finland)

^h UPPSALA UNIVERSITY   (Sweden)

Author keywords

PET; Spastic paraparesis; Variant AD; Visuoconstructive defects

Indexed keywords

GLUCOSE; PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DELETION MUTANT; DEPTH PERCEPTION; EXON; FEMALE; FUNCTIONAL ASSESSMENT; GENE DELETION; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HEMISPHERIC DOMINANCE; HUMAN; INTELLECTUAL IMPAIRMENT; MALE; MEMORY DISORDER; MENTAL DISEASE; MENTAL PERFORMANCE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OCCIPITAL LOBE; ONSET AGE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENILE PLAQUE; SPASTIC PARESIS; SURVIVAL; TASK PERFORMANCE; TEMPORAL LOBE; VERBAL MEMORY; VISUAL MEMORY; VISUAL ORIENTATION;

EID: 0842283362     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2003.10.020     Document Type: Article

References (53)

1. Petersen R.C., Smith G.E., Ivnik R.J., Kokmen E., Tangalos E.G. Memory function in very early Alzheimer's disease. Neurology. 44:1994;867-872.
2. Jacobs D.M., Sano M., Dooneief G., Marder K., Bell K.L., Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology. 45:1995;957-962.
3. Linn R.T., Wolf P.A., Bachman D.L., Knoefel J.E., Cobb J.L., Belanger A.J.et al. The 'preclinical phase' of probable Alzheimer's disease. Arch. Neurol. 52:1995;485-490.
4. Almkvist O. Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol. Scand. Suppl. 165:1996;63-71.
5. Mori E., Yoneda Y., Yamashita H., Hirono N., Ikeda M., Yamadori A. Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J. Neurol. Neurosurg. Psychiatry. 63:1997;214-221.
6. Lendon C.L., Ashall F., Goate A.M. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA. 277:1997;825-831.
7. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L.et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
8. Schellenberg G.D., Bird T.D., Wijsman E.M., Orr H.T., Anderson L., Nemens E.et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 258:1992;668-671.
9. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M.et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
10. The Alzheimer's Disease Collaborative Group, Clark R.F., Hutton M., Fulder R.A., Froelich S., Karran E., Talbot C.et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat. Genet. 11:1995;219-222.
11. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H.et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
12. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y.et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 376:1995;775-778.
13. Diaz-Olavarrieta C., Ostrosky-Solis F., de la Cadena C.G., Rodriguez Y., Alonso E. Neuropsychological changes in subjects at risk of inheriting Alzheimer's disease. Neuroreport. 8:1997;2449-2453.
14. Julin P., Almkvist O., Basun H., Lannfelt L., Svensson L., Winblad B.et al. Brain volumes and regional cerebral blood flow in carriers of the Swedish Alzheimer amyloid protein mutation. Alzheimer Dis. Assoc. Disord. 12:1998;49-53.
15. Crook R., Verkkoniemi A., Perez-Tur J., Mehta N., Baker M., Houlden H.et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat. Med. 4:1998;452-455.
16. Prihar G., Verkkoniemi A., Perez-Tur J., Crook R., Lincoln S., Houlden H.et al. Alzheimer disease PS-1 exon 9 deletion defined. Nat. Med. 1999;1090-1095.
17. Verkkoniemi A., Somer M., Rinne J.O., Myllykangas L., Crook R., Hardy J.et al. Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology. 54:2000;1103-1109.
18. Verkkoniemi A., Kalimo H., Paetau A., Somer M., Iwatsubo T., Hardy J.et al. Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J. Neuropathol. Exp. Neurol. 60:2001;483-492.
19. Houlden H., Baker M., McGowan E., Lewis P., Hutton M., Crook R.et al. Variant Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques is caused by PS-1 mutations which lead to exceptionally high Aβ concentrations. Ann. Neurol. 48:2000;806-808.
20. Smith M.J., Kwok J.B.J., McLean C.A., Kril J.J., Broc G.A., Nicholson G.A. Variable phenotype of Alzheimer's disease with spastic paraparesis. Ann. Neurol. 49:2001;125-129.
21. Erkinjuntti T., Laaksonen R., Sulkava R., Syrjäläinen R., Palo J. Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia. Acta Neurol. Scand. 74:1986;393-403.
22. Wechsler D. A standardized memory scale for clinical use. J. Psychol. 19:1945;87-95.
23. Wechsler D. WMS-R. Wechsler Memory Scale - revised. Manual. 1987;Psychological Corporation/Harcourt Brace Jovanovich, San Antonio.
24. Christensen A.-L. Luria's neuropsychological investigation. 1975;Munksgaard, Copenhagen.
25. Wechsler D. Wechsler adult intelligent scale. Manual. 1955;Psychological Corporation, New York.
26. Lezak M.D. Norms for growing older. Dev. Neuropsychol. 3:1987;1-12.
27. Laine M., Goodglass H., Niemi J., Koivuselkä-Sallinen P., Tuomainen J., Marttila R. Adaptation of the Boston diagnostic aphasia examination and the Boston Naming Test into Finnish. Scand. J. Logop Phoniatr. 18:1993;83-92.
28. Hamacher K., Coenen H.H., Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2 (18F(-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J. Nucl. Med. 27:1986;235-238.
29. Solin O., Bergman J., Haaparanta M., Reissell A.L. Production of 18F from water targets, specific radioactivity, and anionic contaminants. Int. J. Appl. Radiat. Isot. 39:1988;1065-1071.
30. Patlak C.S., Blassberg P.C. Graphical evaluation of blood to brain transfer from multiple-time uptake data: generalizations. J. Cereb. Blood Flow Metab. 5:1985;584-590.
31. Goethals M., Santens P. Posterior cortical atrophy. Clin. Neurol. Neurosurg. 103:2001;115-119.
32. Lampe T.H., Bird T.D., Nochlin D., Nemens E., Risse S.C., Sumi M.et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann. Neurol. 36:1994;368-378.
33. Kwok J.B.J., Taddei K., Hallupp M., Fisher C., Brooks W.S., Broe G.A.et al. Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype. Neuroreport. 8:1997;1537-1542.
34. Karlinsky H., Vaula G., Haines J.L., Ridgley J., Bergeron C., Mortilla M.et al. Molecular and prospective phenotypic characterization of a pedigree with familial Alzheimer's disease and a missense mutation in codon 717 of the β-amyloid precursor protein gene. Neurology. 42:1992;1445-1453.
35. Campion D., Brice A., Hannequin D., Tardieu S., Dubois B., Calenda A.et al. A large pedigree with early-onset Alzheimer's disease. Clinical, neuropathologic, and genetic characterization. Neurology. 45:1995;80-85.
36. Kennedy A.M., Newman S.K., Frackowiak R.S.J., Cunningham V.J., Roques P., Stevens J.et al. Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. Brain. 118:1995;185-205.
37. Fox N.C., Kennedy A.M., Harvey R.J., Lantos P.L., Roques P.K., Collinge J.et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain. 120:1997;491-501.
38. Farlow M., Murrell J., Ghetti B., Unverzagt F., Zeldenrust S., Benson M. Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-T change at position 2149 of the amyloid precursor protein gene. Neurology. 44:1994;105-111.
39. Harvey R.J., Ellison D., Hardy J., Hutton M., Roques P.K., Collinge J.et al. Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-serine (L250S) substitution at codon 250 of the presenilin 1 gene. J. Neurol. Neurosurg. Psychiatry. 64:1998;44-49.
40. Roselli M., Ardila A., Moreno S., Standish V., Arango-Lasprilla J.C., Tirado V.et al. Cognitive decline in patients with familial Alzheimer's disease associated with E280a Presenilin-1 mutation: a longitudinal study. J. Clin. Exp. Neuropsychol. 22:2000;483-495.
41. Campion D., Brice A., Dumanchin C., Puel M., Baulac M., De La Ayette V. et al. A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport. 7:1996;1582-1584.
42. Matsumura Y., Kitamura E., Miyoshi K., Yamamoto Y., Furuyama J.et al. Japanese siblings with missense mutation (717Val-Ile) in amyloid precursor protein of early-onset Alzheimer's disease. Neurology. 46:1996;1721-1723.
43. Almkvist O., Basun H., Wahlund L.-O., Lannfelt L. Cognitive functions of family members with and without the APP 670/671 mutation. Iqbal K., Mortimer J.A., Winblad B., Wisniewski H.M. Research advances in Alzheimer's disease and related disorders. 1995;251-259 Wiley, New York.
44. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B.et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat. Genet. 1:1992;345-347.
45. Lannfelt L., Bogdanovic N., Appelgren H., Axelman K., Lilius L., Hansson G.et al. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci. Lett. 168:1994;254-256.
46. Desgranges B., Baron J.-C., de la Sayette V., Petit-Taboue M.-C., Benali K., Landeau B.et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain. 121:1998;611-631.
47. Hirono N., Mori E., Ishii K., Ikejiri Y., Imamura T., Shimomura T.et al. Hypofunction in the posterior cingulate gyrus correlates with disorientation for time and place in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 64:1998;552-554.
48. Haxby J.V., Grady C.L., Koss E., Horwitz B., Schapiro M., Friedland R.P.et al. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology. 38:1988;1853-1863.
49. Yamaguchi S., Meguro K., Itoh M., Hayasaka C., Shimada M., Yamazaki H.et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J. Neurol. Neurosurg. Psychiatry. 62:1997;596-600.
50. Ischii K., Imamura T., Sasaki M., Yamaji S., Sakamoto S., Kitagaki H.et al. Regional cerebral glucose metabolism in dementia with Lewy bodies. Neurology. 51:1998;125-130.
51. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A.et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47:1996;1113-1124.
52. van Bogaert L., Mare M. Sur les formes familiales precoces de la maladie d'Alzheimer. Monatsc. Psychiatr. Neurol. 102:1940;249-301.
53. Sodeyama N., Shimada M., Uchihara T., Yanagisawa K., Fujigasaki H., Yamaguchi K.et al. Spastic tetraplegia as an initial manifestation of familial Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 59:1995;395-399.